- September 3, 2022
- Newsletter
- 617-430-5616
Menu
» Home » CAD » Endocrinology » Gonadal Disorders » Developmental disorders
ADVERTISEMENT
ADVERTISEMENT
» Home » CAD » Endocrinology » Gonadal Disorders » Developmental disorders
Background
Epidemiology
Anatomy
Pathophysiology
Etiology
Genetics
Prognostic Factors
Clinical History
Physical Examination
Age group
Associated comorbidity
Associated activity
Acuity of presentation
Differential Diagnoses
Laboratory Studies
Imaging Studies
Procedures
Histologic Findings
Staging
Treatment Paradigm
by Stage
by Modality
Chemotherapy
Radiation Therapy
Surgical Interventions
Hormone Therapy
Immunotherapy
Hyperthermia
Photodynamic Therapy
Stem Cell Transplant
Targeted Therapy
Palliative Care
Medication
Indicated for autism:
<5 years: Safety and efficacy not established
5-16 years(<20kg)
Initial dose:0.25mg orally once a day
Titration: A following dose increase may be made in increments of 0.25 mg at intervals of 2 weeks or more, as tolerated, after a minimum of 4 days
Maintain this dose for a minimum of 14 days
5-16 years(>20kg)
Initial dose:0.5mg orally once a day
Titration: A following dose increase may be made in increments of 0.5 mg at intervals of 2 weeks or more, as tolerated, after a minimum of 4 days
Maintain this dose for a minimum of 14 days
Dose Adjustments
Renal impairment
Dosage adjustments may be necessary for mild to moderate renal impairment, but no specific guidelines have been provided. Caution is recommended. For severe renal impairment, the initial starting dose is 0.5 mg twice daily, with increments of 0.5 mg or less administered twice a day. For doses above 1.5 mg twice daily, increase in 1 week or more significant intervals. The long-acting intramuscular injection can be used if a total daily oral dose of at least 2 mg once daily is well tolerated, with an initial dose of 25 mg every two weeks by deep intramuscular injection in the deltoid or gluteal muscle
Liver impairment
Dosage adjustments may be necessary for mild to moderate hepatic dysfunction (Child-Pugh less than 10), but no specific guidelines have been provided. Caution is recommended. For severe hepatic dysfunction (Child-Pugh 10 to 15), the initial starting dose is 0.5 mg twice a day, with increments of 0.5 mg or less, administered twice daily. For doses above 1.5 mg twice daily, increase in 1 week or more significant intervals. The long-acting intramuscular injection can be used if a total daily oral dose of at least 2 mg once daily is well tolerated, with an initial dose of 25 mg every two weeks by deep intramuscular injection in the deltoid or gluteal muscle
Future Trends
References
ADVERTISEMENT
» Home » CAD » Endocrinology » Gonadal Disorders » Developmental disorders
Indicated for autism:
<5 years: Safety and efficacy not established
5-16 years(<20kg)
Initial dose:0.25mg orally once a day
Titration: A following dose increase may be made in increments of 0.25 mg at intervals of 2 weeks or more, as tolerated, after a minimum of 4 days
Maintain this dose for a minimum of 14 days
5-16 years(>20kg)
Initial dose:0.5mg orally once a day
Titration: A following dose increase may be made in increments of 0.5 mg at intervals of 2 weeks or more, as tolerated, after a minimum of 4 days
Maintain this dose for a minimum of 14 days
Dose Adjustments
Renal impairment
Dosage adjustments may be necessary for mild to moderate renal impairment, but no specific guidelines have been provided. Caution is recommended. For severe renal impairment, the initial starting dose is 0.5 mg twice daily, with increments of 0.5 mg or less administered twice a day. For doses above 1.5 mg twice daily, increase in 1 week or more significant intervals. The long-acting intramuscular injection can be used if a total daily oral dose of at least 2 mg once daily is well tolerated, with an initial dose of 25 mg every two weeks by deep intramuscular injection in the deltoid or gluteal muscle
Liver impairment
Dosage adjustments may be necessary for mild to moderate hepatic dysfunction (Child-Pugh less than 10), but no specific guidelines have been provided. Caution is recommended. For severe hepatic dysfunction (Child-Pugh 10 to 15), the initial starting dose is 0.5 mg twice a day, with increments of 0.5 mg or less, administered twice daily. For doses above 1.5 mg twice daily, increase in 1 week or more significant intervals. The long-acting intramuscular injection can be used if a total daily oral dose of at least 2 mg once daily is well tolerated, with an initial dose of 25 mg every two weeks by deep intramuscular injection in the deltoid or gluteal muscle
Founded in 2014, medtigo is committed to providing high-quality, friendly physicians, transparent pricing, and a focus on building relationships and a lifestyle brand for medical professionals nationwide.
USA – BOSTON
60 Roberts Drive, Suite 313
North Adams, MA 01247
INDIA – PUNE
7, Shree Krishna, 2nd Floor, Opp Kiosk Koffee, Shirole Lane, Off FC Road, Pune 411004, Maharashtra
Founded in 2014, medtigo is committed to providing high-quality, friendly physicians, transparent pricing, and a focus on building relationships and a lifestyle brand for medical professionals nationwide.
MASSACHUSETTS – USA
60 Roberts Drive, Suite 313,
North Adams, MA 01247
MAHARASHTRA – INDIA
7, Shree Krishna, 2nd Floor,
Opp Kiosk Koffee,
Shirole Lane, Off FC Road,
Pune 411004, Maharashtra
Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.
On course completion, you will receive a full-sized presentation quality digital certificate.
A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.
When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.